For many industries, innovation helps to drive down product prices. Over the past few decades, entry-level computers have decreased in price from thousands of dollars to only a few hundred. 1980 saw the debut of IBM's personal computer, ...
Cancer Research UK's commercial arm Cancer Research Technology (CRT) has collaborated with Danish drug discovery firm Nuevolution for the discovery of anti-cancer drug molecules targeting several key proteins. The deal is aimed at ...
Tags: Cancer Drugs, Medicine
Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...
Tags: Cancer Drug, Medicine
Calithera Biosciences has completed a $35m series D financing led by Adage Capital Partners, LP. Joining Adage as new investors in this financing are the Longwood Fund and two other institutional investor groups. The transaction also ...
Depomed, a US-based pharmaceutical firm, has launched Lazanda (fentanyl) nasal spray along with a new, dedicated team of regional sales specialists and the signature support program for patients with breakthrough cancer pain. Lazanda is ...
Tags: Lazanda Spray, Medicine
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
KEW Group, the oncology personalized medicine management and analytics company, has launched CancerPlex assay, a comprehensive gene testing panel that can be used to examine the genetic profile of many common cancers. Developed and ...
Tags: Genomic Testing, Medicine
Laboratory Corporation of America Holdings (LabCorp) has announced the nationwide availability of QIAGEN’s therascreen KRAS RGQ PCR kit, a new US Food and Drug Administration (FDA) approved companion diagnostic for certain colorectal ...
Tags: Labcorp, Colorectal Cancer
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
Boehringer Ingelheim has submitted a marketing authorisation application to the European Medicines Agency (EMA) for the approval of its oral triple angiokinase inhibitor nintedanib. Nintedanib to be used in combination with docetaxel is ...
Tags: Boehringer Ingelheim, Lung Cancer
US-based development-stage biopharmaceutical firm Sorrento Therapeutics has acquired Sherrington Pharmaceuticals (Sherrington), a company that provides chronic pain treatment for end-stage cancer patients and other severe pain indications. ...
Tags: Drug, Chronic Pain Treatment
US-based biopharmaceutical company Galena Biopharma has launched the Abstral (fentanyl) sublingual tablets in the US for the treatment of breakthrough cancer pain. The sublingual (under the tongue) fentanyl tablet has been designed for ...
Tags: Sublingual Tablets, Medicine
Bedding major Simmons said it will be a major sponsor of Howard Young's 2013 Atlanta Golf Classic, supporting pancreatic cancer research. Atlanta-based Simmons will co-sponsor the charity golf tournament, which expects to attract 120 ...
Tags: Light Industry, Daily Use
Swiss drugmaker F. Hoffmann-La Roche has announced that the EU’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending authorization of Kadcyla as a single agent for the treatment of adult ...
Tags: Breast Cancer Drug
CancerCare Co-Payment Assistance Foundation has launched its new website and CRM software called 'DiseaseTrak'. Apart from implementing DiseaseTrak, CancerCare will now offer same-day determination and conditional approval for cancer ...
Tags: Cancer Patients, CancerCare